Source: Cornerstone Angels Blog

Cornerstone Angels Blog Endotronix Announces First in Human Implantation

Cornerstone portfolio company, Endotronix, a medical technology company providing device and digital health solutions for heart failure management, announced on January 24th, 2018, a successful first-in-human implantation of the Cordella™ Pulmonary Artery (PA) Pressure Sensor and initiation of the SIRONA First-in-Human … Continue reading →

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Michael Gruber's photo - CEO of Cornerstone Angels

CEO

Michael Gruber

CEO Approval Rating

95/100

Read more